Application of clotrimazole via a novel controlled release device provides potent retinal protection

Age-related macular degeneration is the leading cause of legal blindness among older individuals. Therefore, the development of new therapeutic agents and optimum drug delivery systems for its treatment are crucial. In this study, we investigate whether clotrimazole (CLT) is capable of protecting re...

Descripción completa

Detalles Bibliográficos
Autores principales: Nezhad, Zhaleh Kashkouli, Nagai, Nobuhiro, Yamamoto, Kotaro, Kaji, Hirokazu, Nishizawa, Matsuhiko, Saya, Hideyuki, Nakazawa, Toru, Abe, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Delivery Systems
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559097/
https://www.ncbi.nlm.nih.gov/pubmed/26335210
http://dx.doi.org/10.1007/s10856-015-5561-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559097/
https://www.ncbi.nlm.nih.gov/pubmed/26335210
http://dx.doi.org/10.1007/s10856-015-5561-9

Ejemplares similares